Healthcare Distribution Alliance

Registered Principal Details

Business Or Interest:
Healthcare

Lobbying Interests:
Issues related to Healthcare and the biennial budget.

CEO Name:
Robert Mauch

Contact
MD
Matthew DiLoreto
901 N. Glebe Rd
Arlington, VA 22203
(703) 787-0000
ccastro@multistate.us
https://www.hda.org/

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Roxolana Kozyckyj Exclusive Duties No Authorized On 2/26/2021 Withdrawn On 11/24/2021
Annette M Cruz Exclusive Duties No Authorized On 3/8/2021 Withdrawn On N/A
Nathan J Halbach Exclusive Duties No Authorized On 3/8/2021 Withdrawn On N/A
Michael Rogowski Exclusive Duties No Authorized On 3/8/2021 Withdrawn On N/A
Travis Butchello Exclusive Duties No Authorized On 2/15/2022 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Senate Bill 753
Senate Bill 753
Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.

Bill Text and History

For
Notification Date
1/13/2022
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
7/23/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.
Development, drafting or introduction of a proposal relating to
Drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations.

Action Intended To Affect
Legislative matter

Notification Date
11/5/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations
Development, drafting or introduction of a proposal relating to
drug pricing, licensing, and regulatory oversight of Pharmacy Services Administrative Organizations

Action Intended To Affect
Legislative matter

Notification Date
10/27/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB 3339 - Office of Prescription Drug Affordability
Development, drafting or introduction of a proposal relating to
LRB 3339 - Office of Prescription Drug Affordability

Action Intended To Affect
Legislative matter

Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB 3337 PSAO Licensure
Development, drafting or introduction of a proposal relating to
LRB 3337 PSAO Licensure

Action Intended To Affect
Legislative matter

Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB 3331 - Drug importation
Development, drafting or introduction of a proposal relating to
LRB 3331 - Drug importation

Action Intended To Affect
Legislative matter

Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

LRB 2313 - Prescription Drug Review Board
Development, drafting or introduction of a proposal relating to
LRB 2313 - Prescription Drug Review Board

Action Intended To Affect
Legislative matter

Notification Date
8/16/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
Total Lobbying Expenditures 2021
January - June
$12,045.00
2021
July - December
$15,000.00
2022
January - June
$0.00
2022
July - December
$15,086.00
Total $42,131.00
Total Hours Communicating 2021
January - June
1.00
2021
July - December
3.25
2022
January - June
0.50
2022
July - December
2.00
Total 6.75
Total Hours Other 2021
January - June
7.25
2021
July - December
11.00
2022
January - June
9.75
2022
July - December
5.50
Total 33.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: prohibiting certain practices relating to insurance coverage of clinician-administered drugs.
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
1%
2022
July - December
Total < 1%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
30%
2022
January - June
2022
July - December
75%
Total 25%
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
4%
2022
July - December
Total 1%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
15%
2022
January - June
2022
July - December
15%
Total 8%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
100%
2021
July - December
55%
2022
January - June
95%
2022
July - December
10%
Total 66%

Filed Statements of Lobbying Activity and Expenditures